(Finance) – Pharmacosma company active in the Health, Pharma & Beauty sector, announces that it has obtained admission to trading of its own ordinary shares and warrants on Euronext Growth Milan. The start of negotiations is scheduled for tomorrow 30 March 2022.
The company concluded with successful placement with a request overall equal to approx 2.5 times the quantity offered in capital increase.
Admission took place following the placement aimed exclusively at primary and qualified investors Italian and foreign institutions of 10,222,180 shares ordinary. More specifically, 7,555,540 ordinary shares derive from a share capital increase for a total of 17 million euros, 1,333,320 ordinary shares are put up for sale by certain shareholders of the company and 1,333,320 ordinary shares deriving from the exercise of the over-allotment option, granted to the Global Coordinator illimity Bank.
There will also be overall negotiations from the first day of listing 1,022,218 Warrants with strike price equal to the IPO price, ie € 2.25 in the first conversion window.
The placement price is equal to € 2.25 at the top of the defined price range, with an expected market capitalization, at the start date of trading, of € 75.3 million and an expected free float of 26.57% (30.55% assuming full exercise of the greenshoe option).